Sagimet Biosciences Inc. - Rasio total nilai perusahaan marang pendapatan SGMT

sagimet.com (SGMT) - logo korporat

The EV-to-revenue multiple demonstrates the market's perception of the business value, while 0.00 reflects the baseline level of the metric. Sagimet Biosciences (SGMT) focuses on developing targeted therapies for liver diseases via FASN inhibitors. Prospects depend on the approval of drugs against NASH and patent protection. Potential pricing power in the MASH niche will ensure premium status following FDA certification.

SGMT Sagimet Biosciences: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Sagimet Biosciences, Inc. - rincian analitis lan metrik utama (SGMT)

- rega saham lan prakiraan rega para ahli:
- indikator dhuwit lan arus kas:
Pambiji fundamental perusahaan:SGMT Sagimet Biosciences
Produk asli Sagimet Biosciences Inc.

The EV/Sales ratio measures business value relative to revenue, excluding the impact of debt load. Professionals use it to assess the market premium paid per unit of sales. The current value of 0.00 on the EV/Sales chart from GURU.Markets reflects the current balance of supply and demand. A stabilization of the trend may signal a risk of capital stagnation. For Sagimet Biosciences (SGMT), this confirms the effectiveness of biocomponent supplier diversification, which supports profitability.

Analisis pesaing Sagimet Biosciences

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)